Cargando…

THU651 Testosterone Treatment And Sexual Function In Men With Or At Risk Of T2D: The T4DM Study

Disclosure: G.A. Wittert: Advisory Board Member; Self; Bayer Schering Pharma. Speaker; Self; Bayer Schering Pharma, Besin. K. Robledo: None. M. Grossmann: None. B.B. Yeap: Advisory Board Member; Self; Bayer Schering Pharma. Grant Recipient; Self; Bayer Schering Pharma, Lawley. B.G. Stuckey: None. W....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wittert, Gary Allen, Robledo, Kristy, Grossmann, Mathis, Yeap, Bu Beng, Ann Stuckey, Bronwyn Gwenneth, Inder, Warrick John, Bracken, Karen, Jesudason, David R, Allan, Carolyn A, Handelsman, David J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553962/ http://dx.doi.org/10.1210/jendso/bvad114.1555

Ejemplares similares

FRI434 Long-term Self-reported Outcomes Of Randomized Testosterone (T) vs Placebo (P) Treatment In The T4DM Study
por: Handelsman, David J, et al.
Publicado: (2023)

Recovery of Male Reproductive Endocrine Function Following Prolonged Injectable Testosterone Undecanoate Treatment
por: Shankara-Narayana, Nandini, et al.
Publicado: (2021)

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies
por: Bracken, Karen, et al.
Publicado: (2019)

THU652 Associations Of Testosterone, Dihydrotestosterone, Estradiol And Sex Hormone-binding Globulin With All-cause And Cardiovascular Mortality, And Incident Cardiovascular Events In Men: Individual Participant Data Meta-analyses
por: Yeap, Bu Beng, et al.
Publicado: (2023)

OR25-04 Factors Affecting Testosterone Concentrations In Men: Individual Participant Data Meta-analyses From The Androgens In Men Study
por: Marriott, Ross J, et al.
Publicado: (2023)

THU645 Comparison Of LC-MS/MS Testosterone Assays Towards Standardization Of Lower Testosterone Ranges
por: Cree, Melanie G, et al.
Publicado: (2023)

Obesity, type 2 diabetes, and testosterone in ageing men
por: Wittert, Gary, et al.
Publicado: (2022)

SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

SAT-033 U-Shaped Association of Plasma Testosterone, and No Association of Plasma Estradiol, with Incidence of Any Fracture and Hip Fracture in Older Men
por: Yeap, Bu Beng, et al.
Publicado: (2020)

OR29-4 Prevention of Type 2 Diabetes by Testosterone in the T4DM Trial: Analysis of Effect Mediation
por: Wittert, Gary
Publicado: (2022)

SUN-LB040 Associations of Testosterone and Sex Hormone Binding Globulin with the Risk of Cardiovascular Disease and Type 2 Diabetes in Men
por: Wittert, Gary, et al.
Publicado: (2019)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

THU629 Cluster Analysis Identifies Distinct Subtypes Of PCOS
por: van der Ham, Kim, et al.
Publicado: (2023)

OR25-05 Clinical Predictors Of Symptomatic Benefit In Men With Low Testosterone During Testosterone Treatment Compared With Placebo: Results Of Individual Patient And Aggregate Data Meta-analyses
por: Hudson, Jemma, et al.
Publicado: (2023)

THU646 Postmenopausal Hyperandrogenism Secondary To Ovarian Leydig Cell Tumor
por: Batch, Jennifer Tania, et al.
Publicado: (2023)

THU650 Prevalence Of Hyperandrogenemia, PCOS And Obesity In Mothers Of Daughters With PCOS
por: Cai, Jie, et al.
Publicado: (2023)

SAT-047 Adoption of an Age Adjusted Testosterone Reference Range Reduces Referrals to Endocrine Clinic and New Prescriptions of Testosterone
por: Dewdney, Charlotte, et al.
Publicado: (2020)

THU627 Fertility Outcomes And Anti Mullerian Hormone Levels In Women With Hypopituitarism
por: Fitz, Victoria W, et al.
Publicado: (2023)

THU001 Novel Interactive Text-messaging Curriculum For Endocrinology Board Review
por: Majety, Priyanka, et al.
Publicado: (2023)

OR25-5 Adverse Cardiovascular Events and Cause Mortality in Men During Testosterone Treatment: Individual Patient and Aggregate Data Meta-Analyses
por: Andersen, Marianne, et al.
Publicado: (2022)

THU644 Gene-by-PCOS Interactions In Cardio-metabolic Traits On A Panel Of Genetically Diverse Strains Of Mice
por: Velez, Leandro Martin, et al.
Publicado: (2023)

THU212 Exploring The Experiences Of Adult Patients With Turner Syndrome At A Multidisciplinary Clinic
por: Shin, Sooyoun, et al.
Publicado: (2023)

THU633 Atonal BHLH Transcription Factor 8 (ATOH8) Functions In Decidualization
por: Thapa, Rupak, et al.
Publicado: (2023)

THU647 Patient With Successful Conception During Treatment For Cushing Disease: Case Report
por: Iweha, Chioma, et al.
Publicado: (2023)

THU642 Progression To Cirrhosis And All-cause Mortality Are Increased In Postmenopausal Women With NAFLD
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2023)

SUN-229 The Role of Testosterone in Spermatogenesis: Lessons from Proteome Profiling of Human Spermatozoa in Testosterone Deficiency
por: Grande, Giuseppe, et al.
Publicado: (2019)

THU643 Hyperandrogenism Caused By A Steroid Cell Tumor Of The Ovary In A Postmenopausal Woman
por: Mon Myint, Myat Su, et al.
Publicado: (2023)

THU636 Prevalence Of Metabolic Syndrome In A Sample Of Hispanic Patients With Polycystic Ovary Syndrome
por: Arroyo, Isabel C, et al.
Publicado: (2023)

THU626 Impact Of Body Mass Index On Clinical And Endocrinological Characteristics Of Indian PCOS Population
por: Pandey, Seema, et al.
Publicado: (2023)

SAT-045 Free Testosterone and Cardiometabolic Parameters in Adult Men - Comparison of Algorithms for Calculation of Serum Free Testosterone
por: Holmboe, Stine Agergaard, et al.
Publicado: (2020)

OR25-4 Active Testosterone Treatment Impairs In Vitro Fertilization (IVF) Outcomes in a Female Mouse Model for Gender-Affirming Testosterone with Improvement in Outcomes Following Cessation of Testosterone Treatment
por: Moravek, Molly B, et al.
Publicado: (2022)

THU635 Metabolic Characteristics Among Polycystic Ovary Syndrome-Phenotypes In A Sample Of Hispanic Patients
por: Gonzalez-Rodriguez, Loida Alejandra, et al.
Publicado: (2023)

THU640 Clustering Of Genetic Loci Identifies 4 Distinct Polycystic Ovarian Syndrome Physiologic Pathways
por: Stamou, Maria, et al.
Publicado: (2023)

THU631 Steroyl-CoA Desaturase Is A Progesterone Receptor Target Gene In Uterine Leiomyoma
por: Komorowski, Allison S, et al.
Publicado: (2023)

THU630 Improving Diagnostic Precision In Primary Ovarian Insufficiency Using Comprehensive Genetic And Autoantibody Testing
por: Vogt, Elinor, et al.
Publicado: (2023)

SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment
por: DelConte, Anthony, et al.
Publicado: (2020)

Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021)

THU632 Musculoskeletal Composition And Function In Polycystic Ovary Syndrome: Early Evidence From A Prospective Study
por: Kazemi, Maryam, et al.
Publicado: (2023)

THU625 Med12 Mutation Activates Tryptophan-Kynurenine-ahr Pathway To Promote Growth Of Uterine Leiomyoma
por: Zuberi, Azna, et al.
Publicado: (2023)

OR18-2 Higher Plasma Estradiol Concentration Is Independently Associated with Lower Biological Age, Assessed as Leucocyte Telomere Length, in Older Men
por: Yeap, Bu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ctcdieem2inq3bqoudn0kbugo5